SU

276.15

+0.27%↑

BAS

54.19

-0.13%↓

REP

20.85

-0.43%↓

AM

296.8

-3.45%↓

EXE.US

96.43

+0.22%↑

SU

276.15

+0.27%↑

BAS

54.19

-0.13%↓

REP

20.85

-0.43%↓

AM

296.8

-3.45%↓

EXE.US

96.43

+0.22%↑

SU

276.15

+0.27%↑

BAS

54.19

-0.13%↓

REP

20.85

-0.43%↓

AM

296.8

-3.45%↓

EXE.US

96.43

+0.22%↑

SU

276.15

+0.27%↑

BAS

54.19

-0.13%↓

REP

20.85

-0.43%↓

AM

296.8

-3.45%↓

EXE.US

96.43

+0.22%↑

SU

276.15

+0.27%↑

BAS

54.19

-0.13%↓

REP

20.85

-0.43%↓

AM

296.8

-3.45%↓

EXE.US

96.43

+0.22%↑

Search

Eurofins Scientific SE

Закрыт

62.58 0.94

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

62.56

Макс.

62.96

Ключевые показатели

By Trading Economics

Доход

105M

228M

Продажи

1.9B

3.7B

P/E

Средняя по отрасли

27.271

77.607

Прибыль на акцию

1.221

Дивидендная доходность

1.03

Рентабельность продаж

6.2

Сотрудники

65,694

EBITDA

285M

693M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+25.16% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

1.03%

3.49%

Следующий отчет о доходах

22 июл. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-320M

12B

Предыдущая цена открытия

61.64

Предыдущая цена закрытия

62.58

Техническая оценка

By Trading Central

Уверенность

Weak Bearish Evidence

Eurofins Scientific SE График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

24 апр. 2026 г., 19:19 UTC

Приобретения, слияния, поглощения

Intertek Group Rejects EQT's Revised Offer

24 апр. 2026 г., 23:37 UTC

Приобретения, слияния, поглощения

Scoring the Cook Era -- Barrons.com

24 апр. 2026 г., 20:51 UTC

Приобретения, слияния, поглощения

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 апр. 2026 г., 20:50 UTC

Обсуждения рынка
Главные новостные события

Financial Services Roundup: Market Talk

24 апр. 2026 г., 20:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

24 апр. 2026 г., 20:39 UTC

Приобретения, слияния, поглощения

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 апр. 2026 г., 20:09 UTC

Отчет

Tesla Stock Rises After Upgrade But Heads for Weekly Loss. Why AI Is Key. -- Barrons.com

24 апр. 2026 г., 19:48 UTC

Обсуждения рынка
Главные новостные события

Oil Posts Weekly Gains on Continued Hormuz Closure -- Market Talk

24 апр. 2026 г., 19:25 UTC

Приобретения, слияния, поглощения

Organon Stock Surges 30% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 апр. 2026 г., 19:25 UTC

Приобретения, слияния, поглощения

QXO Continues to Tumble Following TopBuild Deal -- Barrons.com

24 апр. 2026 г., 19:22 UTC

Отчет

Dell AI Infrastructure Deal Shows That Hyperscalers Aren't the Only Players. Plus, Adobe and 4 More Stocks. -- Barrons.com

24 апр. 2026 г., 19:06 UTC

Отчет

Earnings Season Was Supposed to Drive the Stock Market. Why It Hasn't. -- Barrons.com

24 апр. 2026 г., 19:05 UTC

Обсуждения рынка

U.S. Natural Gas Falls As Market Frets Over Storage -- Market Talk

24 апр. 2026 г., 18:30 UTC

Приобретения, слияния, поглощения

Intertek: EQT's GBP54/Shr Offer 'Fundamentally Undervalues Intertek and Its Future Prospects'

24 апр. 2026 г., 18:28 UTC

Приобретения, слияния, поглощения

Intertek Rejects Revised EQT Offer

24 апр. 2026 г., 18:12 UTC

Обсуждения рынка

Precious Metals Rise, But Remain Negative for the Week -- Market Talk

24 апр. 2026 г., 18:06 UTC

Обсуждения рынка

Oil Futures Extend Losses on Plans for U.S.-Iran Talks -- Market Talk

24 апр. 2026 г., 17:42 UTC

Отчет

Even Nvidia Stock Is Getting an Intel Boost. It's on Pace for a Record High. -- Barrons.com

24 апр. 2026 г., 17:28 UTC

Отчет

Palantir Stock Is Down 20% in 2026. Why This Analyst Says It's a Buy. -- Barrons.com

24 апр. 2026 г., 17:28 UTC

Обсуждения рынка

Crypto Fear and Greed Index Slides Back to Neutral -- Market Talk

24 апр. 2026 г., 17:12 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

24 апр. 2026 г., 17:11 UTC

Обсуждения рынка

Apple Seen Gaining Market Share Despite Memory Crunch -- Market Talk

24 апр. 2026 г., 17:09 UTC

Обсуждения рынка
Отчет

Intel Seen With Stronger Long-Term Earnings Power -- Market Talk

24 апр. 2026 г., 17:09 UTC

Приобретения, слияния, поглощения

Organon Stock Surges on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 апр. 2026 г., 17:06 UTC

Отчет
Приобретения, слияния, поглощения

Correction to Advanced Micro Devices Stock Gets Upgraded to Buy. Why It's the Big Winner of Intel Earnings. -- Barrons.com

24 апр. 2026 г., 16:51 UTC

Отчет
Приобретения, слияния, поглощения

Two Big Loan Defaults Add to Pain in Private-Credit Funds -- WSJ

24 апр. 2026 г., 16:20 UTC

Обсуждения рынка
Отчет

Tech, Media & Telecom Roundup: Market Talk

24 апр. 2026 г., 16:20 UTC

Обсуждения рынка
Главные новостные события

Financial Services Roundup: Market Talk

24 апр. 2026 г., 16:20 UTC

Обсуждения рынка
Отчет

Auto & Transport Roundup: Market Talk

24 апр. 2026 г., 16:15 UTC

Обсуждения рынка

Global Commodities Roundup: Market Talk

Сравнение c конкурентами

Изменение цены

Eurofins Scientific SE Прогноз

Целевая цена

By TipRanks

25.16% рост

Прогноз на 12 месяцев

Средняя 77.35 EUR  25.16%

Максимум 81 EUR

Минимум 73.7 EUR

Основано на мнении 2 аналитиков Wall Street, спрогнозировавших целевые цены для Eurofins Scientific SE на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

2 ratings

1

Покупка

1

Удержание

0

Продажа

Техническая оценка

By Trading Central

54.22 / 56.82Поддержка и Сопротивление

Краткосрочная

Weak Bearish Evidence

Среднесрочная

Strong Bullish Evidence

Долгосрочная

Bullish Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Eurofins Scientific SE

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.
help-icon Live chat